# Neurosynaptic Communication Pvt

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurosynaptic-communication-pvt

- Industry: Medical Devices & Equipment
- Headquarters: Bangalore, India
- Website: www.neurosynaptic.com
- Total disclosed funding: $0.7M
- Latest round: Series A (Oct 6, 2016)
- Investors on record: 3

## About

Neurosynaptic Communication Pvt Ltd. focuses on digital healthcare and telemedicine solutions, utilizing innovative technologies to enhance healthcare accessibility in underserved regions, leveraging their proprietary ReMeDi® platform.Founded in 2002 in Bangalore, India, Neurosynaptic Communication Pvt Ltd. (NCPL) specializes in telemedicine solutions and point-of-care diagnostics. The company has not undergone any significant pivots. The founders, Rajeev Kumar and Sameer Sawarkar, have experience in the tech sector, with Sameer currently serving as CEO. In October 2016, NCPL raised INR 44.35 million in Series A funding, marking a significant investment by Axilor Ventures, Indian Angel Network, and Quadria Capital Investment Management. To date, the company has successfully completed 3 deals, and their total raised amount stands at INR 44.35 million, with a current valuation of INR 226.284 million.Neurosynaptic Communications Pvt. Ltd. (NCPL) specializes in digital healthcare and telemedicine solutions, primarily through its proprietary ReMeDi® platform. The platform integrates advanced point-of-care diagnostic devices with cloud-based healthcare ERP systems and telemedicine technology, aimed at improving healthcare accessibility and affordability, especially in underserved communities. It offers a comprehensive suite of services including remote primary screening and consultations, which facilitate efficient healthcare management. NCPL targets rural and remote populations across Asia, Africa, and the United States, enhancing access to healthcare for marginalized groups. They collaborate with entities such as the HCL Foundation and the Bill & Melinda Gates Foundation to implement extensive digital health initiatives.In 2023, NCPL reported revenue of INR 1,341,255.20 and an EBITDA of INR 125,562. The company's revenue primarily comes from partnerships with government organizations and non-profits, through which they provide healthcare technology solutions and telemedicine services on a contract basis. Their business model includes B2B relationships where they sell ReMeDi® diagnostic solutions and telemedicine services to healthcare providers in underserved regions. Key revenue streams include service contracts, licensing agreements, and ongoing support associated with their technology solutions.Neurosynaptic Communication Pvt Ltd. plans to leverage its recent funding from the Series A round in October 2016, which raised INR 44.35 million, to enhance its product offerings and expand its market reach. They are focused on the development of new products to enhance their ReMeDi® platform, aiming for diverse healthcare diagnostics applications. Additionally, the company is exploring expansion into new geographic markets, particularly targeting regions in Africa and South Asia by 2025, to extend their impact in digital healthcare solutions. The funding will be utilized to support these initiatives, ensuring that NCPL continues to innovate and provide essential healthcare services in underserved communities.

## Funding rounds

- Series A, Oct 6, 2016, $0.7M — Indian Angel Network, Quadria Capital Investment Management, Axilor Ventures

## Investors

- Indian Angel Network (https://capitalatlas.ai/funds/indian-angel-network) — Series A
- Quadria Capital Investment Management (https://capitalatlas.ai/funds/quadria-capital-investment-management) — Series A
- Axilor Ventures (https://capitalatlas.ai/funds/axilor-ventures) — Series A